Lantheus Holdings Stock Today
| LNTH Stock | USD 103.28 1.06 1.04% |
PerformanceModest
| Odds Of DistressVery Small
|
Lantheus Holdings is trading at 103.28 as of the 20th of March 2025. This is a 1.04 percent increase since the beginning of the trading day. The stock's open price was 102.22. Lantheus Holdings has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of June 2015 | Category Healthcare | Classification Health Care |
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts. The company has 68.48 M outstanding shares of which 7.31 M shares are now shorted by private and institutional investors with about 6.26 trading days to cover. More on Lantheus Holdings
Moving against Lantheus Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Lantheus Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Mary Heino | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Trump Equities (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Drug Manufacturers - Specialty & Generic, Health Care, SP Midcap 400, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Trump Equities, Health Care, Health Care Equipment & Supplies, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsLantheus Holdings can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Lantheus Holdings' financial leverage. It provides some insight into what part of Lantheus Holdings' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lantheus Holdings (LNTH) is traded on NASDAQ Exchange in USA. It is located in 201 Burlington Road, Bedford, MA, United States, 01730 and employs 808 people. Lantheus Holdings is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7 B. Lantheus Holdings conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 68.48 M outstanding shares of which 7.31 M shares are now shorted by private and institutional investors with about 6.26 trading days to cover.
Lantheus Holdings currently holds about 171.43 M in cash with 544.75 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.49.
Check Lantheus Holdings Probability Of Bankruptcy
Ownership AllocationThe majority of Lantheus Holdings outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Lantheus Holdings to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Lantheus Holdings. Please pay attention to any change in the institutional holdings of Lantheus Holdings as this could imply that something significant has changed or is about to change at the company.
Check Lantheus Ownership Details
Lantheus Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.3 M | |
| Swedbank Ab | 2024-12-31 | 1.1 M | |
| T. Rowe Price Associates, Inc. | 2024-12-31 | 1.1 M | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 985 K | |
| Macquarie Group Ltd | 2024-12-31 | 982.9 K | |
| Silvercrest Asset Management Group Llc | 2024-12-31 | 973.9 K | |
| Northern Trust Corp | 2024-12-31 | 916.4 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 814.2 K | |
| Portolan Capital Management, Llc | 2024-12-31 | 812.6 K | |
| Blackrock Inc | 2024-12-31 | 8.6 M | |
| Vanguard Group Inc | 2024-12-31 | 7.2 M |
Lantheus Holdings Historical Income Statement
Lantheus Stock Against Markets
Lantheus Holdings Corporate Management
| Lee Howe | Chief Officer | Profile | |
| Daniel Niedzwiecki | General Officer | Profile | |
| Dorothy Barr | Senior Operations | Profile | |
| Paul Blanchfield | Chief Officer | Profile | |
| Amanda Morgan | Senior Commercial | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantheus Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Lantheus Stock please use our How to Invest in Lantheus Holdings guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantheus Holdings. If investors know Lantheus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantheus Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 4.36 | Revenue Per Share | Quarterly Revenue Growth 0.105 | Return On Assets |
The market value of Lantheus Holdings is measured differently than its book value, which is the value of Lantheus that is recorded on the company's balance sheet. Investors also form their own opinion of Lantheus Holdings' value that differs from its market value or its book value, called intrinsic value, which is Lantheus Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantheus Holdings' market value can be influenced by many factors that don't directly affect Lantheus Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantheus Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantheus Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantheus Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.